3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
4
Burkitt Lymphoma
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Hodgkin Disease
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Recurrence
1
Precancerous Conditions
1
Polycythemia Vera
1
Plasmablastic Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
Specimen Handling
34
Carboplatin
32
pembrolizumab
28
Pemetrexed
27
Magnetic Resonance Spectroscopy
27
Cisplatin
22
Paclitaxel
15
Gemcitabine
13
durvalumab
12
Docetaxel
12
osimertinib
11
Nivolumab
11
atezolizumab
8
Immunoglobulin G
8
Disulfides
8
Taxes
7
Etoposide
7
130-nm albumin-bound paclitaxel
7
Radiotherapy
6
Radiosurgery
6
Radiation
6
Platinum
6
Cetuximab
6
Biopsy
6
X-Rays
5
1,2-diaminocyclohexaneplatinum II citrate
5
Ramucirumab
4
Observation
4
Irinotecan
4
Albumin-Bound Paclitaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Peripheral Blood Stem Cell Transplantation
×
30 days
×
Clear all
No trials found.